Pursuant to Regulation 34 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Annual Report of the Company for the financial year ended 2024-2025 including Notice convening the 21st Annual General Meeting of the Company, to be held on Tuesday, 30th September, 2025 at 02:30 pm. through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM'). Kindly take the above information on your record.

pdf

Indo US Bio-Tech Ltd.

28 Aug 2025

134.40

-0.15%

AGM

Indo Us Bio-Tech Ltd - 541304 - Annual Report

BSE India

Annual Report for the year 2024-2025

pdf

Indo US Bio-Tech Ltd.

28 Aug 2025

134.40

-0.15%

AGM

Indo Us Bio-Tech Ltd - 541304 - Intimation Of Book Closure For The Purpose Of 21St …

BSE India

Book Closure for AGM Purpose

pdf

Indo US Bio-Tech Ltd.

28 Aug 2025

134.40

-0.15%

AGM

Indo Us Bio-Tech Ltd - 541304 - Shareholder Meeting-AGM On September 30, 2025

BSE India

Notice of 21st Annual General Meeting

pdf

Indo US Bio-Tech Ltd.

28 Aug 2025

134.40

-0.15%

Corp. Note

Indo Us Bio-Tech Ltd - 541304 - Board Meeting Outcome for Outcome Of The Board Meeting …

BSE India

Outcome of BM

pdf

Indo US Bio-Tech Ltd.

13 Aug 2025

134.40

-0.15%

Company Update

Indo Us Bio-Tech Ltd - 541304 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication of Unaudited Financial Results for the quarter ended on 30th June, 2025

pdf

Indo US Bio-Tech Ltd.

12 Aug 2025

134.40

-0.15%

Result

Indo Us Bio-Tech Ltd - 541304 - Financial Results For June 30, 2025

BSE India

Financial Results for the quarter ended on 30-06-2025.

pdf

Indo US Bio-Tech Ltd.

12 Aug 2025

134.40

-0.15%

Board Meeting

Indo Us Bio-Tech Ltd - 541304 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

Dear Sir, Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held on Tuesday, 12th August, 2025 at the registered office of the Company situated at 309, Shanti Mall, Satadhar Char Rasta, Opp. Navrang Tower, Sola Road, Ahmedabad, Gujarat, 380061 have considered and approved the following items of business: 1. The Board approved unaudited financial results of the company for the quarter ended 30th June, 2025 along with limited review reports obtained from the Auditor of the Company. The Board Meeting commenced at 14.00 P.M. and concluded at 14:30 P.M. You are requested to kindly take the same on record. Thanking you,

pdf

VOTE: Is Indo Us Bio-Tech Ltd. worth buying?

29 Votes:

Buy 89.66%

Sell 6.9%

Hold 3.45%